1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Associations of gut microbiota features and circulating metabolites with systemic inflammation in children

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          Gut microbes and microbe-dependent metabolites (eg, tryptophan-kynurenine-serotonin pathway metabolites) have been linked to systemic inflammation, but the microbiota-metabolite-inflammation axis remains uncharacterised in children. Here we investigated whether gut microbiota features and circulating metabolites (both microbe-dependent and non-microbe-dependent metabolites) associated with circulating inflammation markers in children.

          Methods

          We studied children from the prospective Gen3G birth cohort who had data on untargeted plasma metabolome (n=321 children; Metabolon platform), gut microbiota (n=147; 16S rRNA sequencing), and inflammation markers (plasminogen activator inhibitor-1 (PAI-1), monocyte chemoattractant protein-1, and tumour necrosis factor-α) measured at 5–7 years. We examined associations of microbial taxa and metabolites—examining microbe-dependent and non-microbe-dependent metabolites separately—with each inflammatory marker and with an overall inflammation score (InfSc), adjusting for key confounders and correcting for multiple comparisons. We also compared the proportion of significantly associated microbe-dependent versus non-microbe-dependent metabolites, identified a priori (Human Microbial Metabolome Database), with each inflammation marker.

          Results

          Of 335 taxa tested, 149 were associated (q FDR<0.05) with at least one inflammatory marker; 10 of these were robust to pseudocount choice. Several bacterial taxa involved in tryptophan metabolism were associated with inflammation, including kynurenine-degrading Ruminococcus, which was inversely associated with all inflammation markers. Of 1037 metabolites tested, 315 were previously identified as microbe dependent and were more frequently associated with PAI-1 and the InfSc than non-microbe dependent metabolites. In total, 87 metabolites were associated (q FDR<0.05) with at least one inflammation marker, including kynurenine (positively), serotonin (positively), and tryptophan (inversely).

          Conclusion

          A distinct set of gut microbes and microbe-dependent metabolites, including those involved in the tryptophan-kynurenine-serotonin pathway, may be implicated in inflammatory pathways in childhood.

          Related collections

          Most cited references45

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms

          DNA sequencing continues to decrease in cost with the Illumina HiSeq2000 generating up to 600 Gb of paired-end 100 base reads in a ten-day run. Here we present a protocol for community amplicon sequencing on the HiSeq2000 and MiSeq Illumina platforms, and apply that protocol to sequence 24 microbial communities from host-associated and free-living environments. A critical question as more sequencing platforms become available is whether biological conclusions derived on one platform are consistent with what would be derived on a different platform. We show that the protocol developed for these instruments successfully recaptures known biological results, and additionally that biological conclusions are consistent across sequencing platforms (the HiSeq2000 versus the MiSeq) and across the sequenced regions of amplicons.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            A new method for non-parametric multivariate analysis of variance

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life.

              The gut microbiota is central to human health, but its establishment in early life has not been quantitatively and functionally examined. Applying metagenomic analysis on fecal samples from a large cohort of Swedish infants and their mothers, we characterized the gut microbiome during the first year of life and assessed the impact of mode of delivery and feeding on its establishment. In contrast to vaginally delivered infants, the gut microbiota of infants delivered by C-section showed significantly less resemblance to their mothers. Nutrition had a major impact on early microbiota composition and function, with cessation of breast-feeding, rather than introduction of solid food, being required for maturation into an adult-like microbiota. Microbiota composition and ecological network had distinctive features at each sampled stage, in accordance with functional maturation of the microbiome. Our findings establish a framework for understanding the interplay between the gut microbiome and the human body in early life.
                Bookmark

                Author and article information

                Contributors
                Journal
                BMJ Open Gastroenterol
                BMJ Open Gastroenterol
                bmjgast
                bmjgast
                BMJ Open Gastroenterology
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                2054-4774
                2024
                29 August 2024
                : 11
                : 1
                : e001470
                Affiliations
                [1 ]departmentLifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center , University of Colorado Anschutz Medical Campus , Aurora, Colorado, USA
                [2 ]departmentDepartment of Epidemiology , University of Colorado Anschutz Medical Campus , Aurora, Colorado, USA
                [3 ]Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke (CHUS) , Sherbrooke, Québec, Canada
                [4 ]departmentDepartment of Biochemistry and Functional Genomics , Université de Sherbrooke , Sherbrooke, Québec, Canada
                [5 ]departmentDepartment of Medical Biology , CIUSSS-SLSJ , Saguenay, Québec, Canada
                [6 ]departmentDepartment of Medicine , Université de Sherbrooke , Sherbrooke, Québec, Canada
                [7 ]departmentDepartment of Population Medicine , Harvard Pilgrim Health Care Institute , Boston, Massachusetts, USA
                [8 ]departmentDiabetes Unit , Massachusetts General Hospital , Boston, MA, USA
                [9 ]departmentDepartment of Pediatrics Section of Nutrition , School of Medicine, University of Colorado Anschutz Medical Campus , Aurora, Colorado, USA
                Author notes

                Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.

                Additional supplemental material is published online only. To view, please visit the journal online ( https://doi.org/10.1136/bmjgast-2024-001470).

                NTM is on the scientific advisory board for Tiny Health; however, this organisation provided no funding for this research nor had any impact on the results or interpretation of the data.

                Author information
                http://orcid.org/0000-0001-8961-6968
                Article
                bmjgast-2024-001470
                10.1136/bmjgast-2024-001470
                11367355
                39209769
                e3690a80-3ae9-464a-82c4-b9e8f1815cec
                Copyright © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

                This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:  http://creativecommons.org/licenses/by-nc/4.0/.

                History
                : 20 May 2024
                : 08 August 2024
                Funding
                Funded by: NHLBI;
                Award ID: K01HL141589
                Award ID: R01HL166473
                Funded by: Canadian Institute of Health Research (CIHR);
                Award ID: 20697
                Award ID: Gen3G
                Award ID: MOP 115071
                Award ID: PJT152989
                Funded by: NIDDK;
                Award ID: R21DK132310
                Funded by: Canadian Institutes of Health Research (CIHR);
                Award ID: BMB 389354
                Categories
                Original Research
                Inflammation
                1506

                inflammation,molecular epidemiology,inflammatory mechanisms

                Comments

                Comment on this article